0.2486
0.80%
-0.002
전일 마감가:
$0.2506
열려 있는:
$0.2473
하루 거래량:
330.02K
Relative Volume:
1.07
시가총액:
$1.94M
수익:
-
순이익/손실:
$-8.74M
주가수익비율:
-0.7769
EPS:
-0.32
순현금흐름:
$-8.25M
1주 성능:
-6.58%
1개월 성능:
-85.88%
6개월 성능:
-87.75%
1년 성능:
-75.79%
Glucotrack Inc Stock (GCTK) Company Profile
명칭
Glucotrack Inc
전화
972 (8) 675-7878
주소
301 RT 17 NORTH, RUTHERFORD
GCTK을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.2486 | 1.94M | 0 | -8.74M | -8.25M | -0.32 |
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Glucotrack Inc 주식(GCTK)의 최신 뉴스
GCTK stock touches 52-week low at $0.23 amid market challenges - Investing.com Australia
GCTK stock touches 52-week low at $0.23 amid market challenges By Investing.com - Investing.com South Africa
Glucotrack enters material agreements following public offering - Investing.com
Glucotrack enters material agreements following public offering By Investing.com - Investing.com UK
Glucotrack announces pricing of $10M public offering - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.11% - MSN
GlucoTrack Inc. (GCTK) Quarterly 10-Q Report - Quartzy
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt - The Manila Times
GlucoTrack Completes Funding to Enhance Financial Stability - TipRanks
Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) - The Manila Times
Glucotrack Secures $10M Through Public Offering, Converts $4M Debt to Equity | GCTK Stock News - StockTitan
STXS Stock Drops 5% Despite Strong Buy Ratings from Analysts - GuruFocus.com
Glucotrack announces $10 million public offering By Investing.com - Investing.com Canada
GCTK stock touches 52-week low at $0.42 amid market fluctuations - Investing.com Australia
500: Something went wrong - Investing.com Canada
S&P 500 Tops 6,000; Rumble Shares Slide After Q3 Results - Benzinga
Dow Jumps Over 150 Points; CyberArk Posts Upbeat Earnings - Benzinga
U.S. Stock market: Syros Pharmaceuticals(−86.21%), GlucoTrack(−77.70%) and others among the most volatile stocks during mid day trading - Business Upturn
U.S. Stock market: Syros Pharmaceuticals surges by 680.00% while Spirit Airlines rises by 184.96% in early trading - Business Upturn
US Stocks Mixed; Inflation Rate Increases In October - Benzinga
GlucoTrack prices 7.2M shares at $1.39 in public offering - TipRanks
Glucotrack announces $10 million public offering - Investing.com
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering - The Manila Times
Fogo de Chão Launches Pro-Athlete 'Meat & Greet” Event Series With National Sports Teams - The Manila Times
Glucotrack (GCTK) Launches $10M Public Offering, Plans Note Conversion Deal | GCTK Stock News - StockTitan
Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.65% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.66% - MSN
AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.67% - MSN
GlucoTrack (NASDAQ:GCTK) to Present Continuous Blood Glucose Monitor at 2024 BioFuture Meeting** - Defense World
Say Goodbye To Finger Pricks! Glucotrack($GCTK)’s Long-Lasting Glucose Monitor Is Here - MSN
GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan
GlucoTrack to Unveil Implantable Glucose Monitor at BioFuture - TipRanks
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE - The Manila Times
GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 - MSN
GlucoTrack (NASDAQ:GCTK) Stock Price Down 1.4% – Here’s What Happened - Defense World
Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology - Nasdaq
GlucoTrack Showcases Innovations at Diabetes Tech Meeting - TipRanks
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING - EIN News
Glucotrack shareholders approve pivotal issuance proposal - Investing.com India
Glucotrack shareholders approve pivotal issuance proposal By Investing.com - Investing.com Canada
Hand-held Glucose Meter Market Growth Ourlook – OrbisResearch - Economica
Godolphin Resources Unveils Comprehensive 2024 Annual Report - TipRanks
Globavend Holdings Limited Announces First Half 2024 Unaudited Financial Results - GlobeNewswire
Global Petroleum Expands Australian Exploration - TipRanks
Qwic owner EcoMotion saves cycling gear brand AGU from downfall - Bike Europe
GPT Infraprojects Secures ₹204 Crore Railway Contract - Indiainfoline
Local Winter Classic competitors clash again in SA Oaks final - The Border Watch
Greenlane to distribute new drug detection strips - Investing.com
GyC hits Kenya, South Africa, Mozambique for mega tour - Guardian Nigeria
Glucotrack Inc (GCTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):